Tishra Beeson1, Susan Wood2, Brian Bruen2, Debora Goetz Goldberg2, Holly Mead2, Sara Rosenbaum2. 1. Department of Health Policy, The George Washington University School of Public Health and Health Services, Washington, DC 2006, USA. Electronic address: tbeeson@gwu.edu. 2. Department of Health Policy, The George Washington University School of Public Health and Health Services, Washington, DC 2006, USA.
Abstract
OBJECTIVE(S): This study examines the on-site availability of long-acting reversible contraception (LARC) methods, defined here as intrauterine devices and contraceptive implants, at Federally Qualified Health Centers (FQHCs). We also describe factors associated with on-site availability and specific challenges and barriers to providing on-site access to LARC as reported by FQHCs. STUDY DESIGN: An original survey of 423 FQHC organizations was fielded in 2011. RESULTS: Over two thirds of FQHCs offer on-site availability of intrauterine devices yet only 36% of FQHCs report that they offer on-site contraceptive implants. Larger FQHCs and FQHCs receiving Title X Family Planning program funding are more likely to provide on-site access to LARC methods. Other organizational and patient characteristics are associated with the on-site availability of LARC methods, though this relationship varies by the type of method. The most commonly reported barriers to providing on-site access to LARC methods are related to the cost of stocking or supplying the drug and/or device, the perceived lack of staffing and training, and the unique needs of special populations. CONCLUSION: Our findings indicate that patients seeking care in small FQHC organizations, FQHCs with limited dedicated family planning funding and FQHCs located in rural areas may have fewer choices and limited access to LARC methods on-site. IMPLICATIONS: Despite the presumed widespread coverage of contraceptives for women as a result of provisions in the Affordable Care Act, there is a limited understanding of how FQHCs may redesign their practices to provide on-site availability of LARC methods. This study sheds light on the current state of practice and challenges related to providing LARC methods in FQHC settings.
OBJECTIVE(S): This study examines the on-site availability of long-acting reversible contraception (LARC) methods, defined here as intrauterine devices and contraceptive implants, at Federally Qualified Health Centers (FQHCs). We also describe factors associated with on-site availability and specific challenges and barriers to providing on-site access to LARC as reported by FQHCs. STUDY DESIGN: An original survey of 423 FQHC organizations was fielded in 2011. RESULTS: Over two thirds of FQHCs offer on-site availability of intrauterine devices yet only 36% of FQHCs report that they offer on-site contraceptive implants. Larger FQHCs and FQHCs receiving Title X Family Planning program funding are more likely to provide on-site access to LARC methods. Other organizational and patient characteristics are associated with the on-site availability of LARC methods, though this relationship varies by the type of method. The most commonly reported barriers to providing on-site access to LARC methods are related to the cost of stocking or supplying the drug and/or device, the perceived lack of staffing and training, and the unique needs of special populations. CONCLUSION: Our findings indicate that patients seeking care in small FQHC organizations, FQHCs with limited dedicated family planning funding and FQHCs located in rural areas may have fewer choices and limited access to LARC methods on-site. IMPLICATIONS: Despite the presumed widespread coverage of contraceptives for women as a result of provisions in the Affordable Care Act, there is a limited understanding of how FQHCs may redesign their practices to provide on-site availability of LARC methods. This study sheds light on the current state of practice and challenges related to providing LARC methods in FQHC settings.
Authors: Kate Coleman-Minahan; Chloe H Dillaway; Caitlin Canfield; Daniela M Kuhn; Katherine S Strandberg; Joseph E Potter Journal: Perspect Sex Reprod Health Date: 2018-12-03
Authors: Kristine Hopkins; Kari White; Fran Linkin; Celia Hubert; Daniel Grossman; Joseph E Potter Journal: Perspect Sex Reprod Health Date: 2015-01-30
Authors: Lauryn P Roth; Jessica N Sanders; Rebecca G Simmons; Holly Bullock; Elizabeth Jacobson; David K Turok Journal: Contraception Date: 2018-03-21 Impact factor: 3.375
Authors: Anna W Brittain; Heather D Tevendale; Trisha Mueller; Aniket D Kulkarni; Dawn Middleton; Michela L B Garrison; Mary R Read-Wahidi; Emilia H Koumans Journal: J Community Health Date: 2020-06
Authors: Michel Boudreaux; Liyang Xie; Yoon Sun Choi; Dylan Habeeb Roby; Michael S Rendall Journal: Am J Public Health Date: 2020-06-18 Impact factor: 9.308